Tag: shanghai junshi biosciences co., ltd.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to shanghai junshi biosciences co., ltd.

Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for ...

Added to Collection on: 2021-03-03 17:03:45

Tags for this article:

Drugs
Clinical medicine
Health care
Orphan drugs
Monoclonal antibodies
Breakthrough therapy
Bevacizumab
Bamlanivimab/etesevimab
Cancer immunotherapy
Nasopharyngeal carcinoma
Nivolumab
Pembrolizumab
Shanghai
shanghai junshi biosciences co., ltd.
Coherus Biosciences Inc.
Junshi Biosciences
United States
Canada
China

Click the tags to see associated articles and topics

View Article Details
CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application ...

Added to Collection on: 2021-03-08 03:42:22

Tags for this article:

Life Sciences
Clinical medicine
Medicine
Biotechnology
Immune system
Immunology
Cancer immunotherapy
Transforming growth factor beta
Programmed cell death protein 1
Monoclonal antibody
Immunotherapy
Biopharmaceutical
CMAB Biopharma (Suzhou) Inc.
China
shanghai junshi biosciences co., ltd.

Click the tags to see associated articles and topics

View Article Details
Adalimumab Biosimilar Wins NMPA Approval - Food, Drugs, Healthcare, Life Sciences - Mondaq

Added to Collection on: 2022-03-10 08:40:13

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Monoclonal antibodies
Rheumatology
TNF inhibitors
Autoimmune diseases
Immunosuppressants
Adalimumab
Infliximab
Biopharmaceutical
shanghai junshi biosciences co., ltd.
Sinopharm

Click the tags to see associated articles and topics

View Article Details
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi ...

Added to Collection on: 2023-10-28 16:14:08

Tags for this article:

Antineoplastic drugs
Orphan drugs
Breakthrough therapy
Cancer treatments
Cancer immunotherapy
TIGIT
Checkpoint inhibitor
Chemotherapy
Enteropathy-associated T-cell lymphoma
Treatment of lung cancer
Durvalumab
Shanghai
Gemcitabine
shanghai junshi biosciences co., ltd.
Coherus Biosciences Inc.
United States
China
Cisplatin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details